Background: Anthrax is a potential biological weapon and can be used in an air-borne or mail attack, such as in the attack in the United States in 2001. Planning for such an event requires the best available science. Since large-scale experiments are not feasible, mathematical modelling is a crucial tool to inform planning. The aim of this study is to systematically review and evaluate the approaches to mathematical modelling of inhalational anthrax attack to support public health decision making and response.

Methods: A systematic review of inhalational anthrax attack models was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. The models were reviewed based on a set of defined criteria, including the inclusion of atmospheric dispersion component and capacity for real-time decision support.

Results: Of 13 mathematical modelling studies of human inhalational anthrax attacks, there were six studies that took atmospheric dispersion of anthrax spores into account. Further, only two modelling studies had potential utility for real-time decision support, and only one model was validated using real data.

Conclusion: The limited modelling studies available use widely varying methods, assumptions, and data. Estimation of attack size using different models may be quite different, and is likely to be under-estimated by models which do not consider weather conditions. Validation with available data is crucial and may improve models. Further, there is a need for both complex models that can provide accurate atmospheric dispersion modelling, as well as for simpler modelling tools that provide real-time decision support for epidemic response.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1049023X20000734DOI Listing

Publication Analysis

Top Keywords

inhalational anthrax
16
mathematical modelling
12
atmospheric dispersion
12
real-time decision
12
modelling studies
12
systematic review
8
attack models
8
human inhalational
8
public health
8
health decision
8

Similar Publications

Anthrax is a fatal zoonotic disease caused by exposure to spores. The CDC's guidelines divide anthrax treatment into three categories according to disease progression: post-exposure prophylaxis (PEP), systemic, and systemic with a suspicion of CNS infection. While the prognosis for PEP or the early treatment of systemic anthrax is very good, ingress of the bacteria into the CNS poses a substantial clinical challenge.

View Article and Find Full Text PDF

Omadacycline is active and against ciprofloxacin-resistant .

Antimicrob Agents Chemother

September 2024

Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania, USA.

, the causative agent of anthrax, is among the most likely bacterial pathogens to be used in a biological attack. Inhalation anthrax is a serious, life-threatening form of infection, and the mortality from acute inhaled anthrax can approach 100% if not treated early and aggressively. Food and Drug Administration-approved antibiotics indicated for post-exposure prophylaxis (PEP) or treatment of anthrax are limited.

View Article and Find Full Text PDF

Possible Bioterrorism by North Korea and South Korea's Preparedness.

Infect Chemother

September 2024

Department of Plastic Surgery, Armed Forces Capital Hospital, Seongnam, Korea.

This paper reviews the elements and infection mechanisms of bioterrorism, assess North Korea's capability for biological warfare, and propose strategies for South Korea to counter potential bioterrorist threats from the North. The four critical elements of bioterrorism include the biological agent, the weaponization of the agent, the delivery system, and the impact of weather conditions on the attack. The infection routes for biological agents in bioterrorism include inhalation, ingestion, dermal exposure, and injection.

View Article and Find Full Text PDF
Article Synopsis
  • * The German Medicinal Products Act (AMG) allows pharmacies to prepare medicinal products, including test allergens, without needing a marketing authorization, which could help fill the diagnostic gap.
  • * The text discusses the practical and legal challenges of creating skin prick test solutions in pharmacies while exploring potential allergen sources and their implications.
View Article and Find Full Text PDF

Rapid activity of telavancin against and protection against inhalation anthrax infection in the rabbit model.

Antimicrob Agents Chemother

July 2024

Product Development Division, Cumberland Pharmaceuticals, Nashville, Tennessee, USA.

Inhalation anthrax is the most severe form of infection, often progressing to fatal conditions if left untreated. While recommended antibiotics can effectively treat anthrax when promptly administered, strains engineered for antibiotic resistance could render these drugs ineffective. Telavancin, a semisynthetic lipoglycopeptide antibiotic, was evaluated in this study as a novel therapeutic against anthrax disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!